Suleika Jaouad's leukemia experience highlights the importance of mindfulness and support networks in managing the disease.

Dr. Elena Elimova discusses how Ziihera-based therapy may change treatment for HER2+ locally advanced or metastatic ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Dr. William A. Hall sat down with CURE for a live interview at the 2026 ASCO Gastrointestinal Cancers Symposium to discuss ...

Hearing the word cancer changes the air in the room, even if you suspected something was wrong. You may feel numb. Panicked.

ECOG performance status was found to capture only part of the patient experience in gastric/GEJ adenocarcinoma. Among patients with gastric or gastroesophageal junction (GEJ) adenocarcinoma, those ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...

Dr. William A. Hall discusses overtreatment in gastrointestinal cancer care and how AI-driven response assessment is shaping personalized treatment.

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Dr. Erika Hamilton spoke with CURE’s editor-in-chief, Dr. Joshua K. Sabari.

When I later calculated the financial impact of survivorship, the numbers were staggering: more than $1 million in lost ...

Zoldonrasib targets KRAS G12D-mutated non-small cell lung cancer, receiving FDA breakthrough therapy designation for its ...